全文获取类型
收费全文 | 5403篇 |
免费 | 271篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 203篇 |
妇产科学 | 215篇 |
基础医学 | 621篇 |
口腔科学 | 285篇 |
临床医学 | 374篇 |
内科学 | 1202篇 |
皮肤病学 | 41篇 |
神经病学 | 577篇 |
特种医学 | 220篇 |
外科学 | 790篇 |
综合类 | 12篇 |
预防医学 | 224篇 |
眼科学 | 80篇 |
药学 | 332篇 |
中国医学 | 11篇 |
肿瘤学 | 450篇 |
出版年
2023年 | 38篇 |
2022年 | 61篇 |
2021年 | 150篇 |
2020年 | 92篇 |
2019年 | 129篇 |
2018年 | 138篇 |
2017年 | 106篇 |
2016年 | 128篇 |
2015年 | 131篇 |
2014年 | 184篇 |
2013年 | 282篇 |
2012年 | 451篇 |
2011年 | 383篇 |
2010年 | 230篇 |
2009年 | 226篇 |
2008年 | 334篇 |
2007年 | 338篇 |
2006年 | 325篇 |
2005年 | 362篇 |
2004年 | 329篇 |
2003年 | 285篇 |
2002年 | 258篇 |
2001年 | 45篇 |
2000年 | 57篇 |
1999年 | 72篇 |
1998年 | 41篇 |
1997年 | 53篇 |
1996年 | 34篇 |
1995年 | 29篇 |
1994年 | 39篇 |
1993年 | 36篇 |
1992年 | 33篇 |
1991年 | 34篇 |
1990年 | 25篇 |
1989年 | 21篇 |
1988年 | 29篇 |
1987年 | 15篇 |
1986年 | 11篇 |
1985年 | 20篇 |
1984年 | 14篇 |
1983年 | 18篇 |
1982年 | 7篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1974年 | 5篇 |
1973年 | 8篇 |
1969年 | 5篇 |
排序方式: 共有5703条查询结果,搜索用时 406 毫秒
101.
Christian Rummel Christoph Zubler Gerhard Schroth Jan Gralla Kety Hsieh Eugenio Abela Martinus Hauf Niklaus Meier Rajeev K Verma Robert H Andres Arto C Nirkko Roland Wiest 《Journal of cerebral blood flow and metabolism》2014,34(2):347-356
We report on oxygenation changes noninvasively recorded by multichannel continuous-wave near infrared spectroscopy (CW-NIRS) during endovascular neuroradiologic interventions requiring temporary balloon occlusion of arteries supplying the cerebral circulation. Digital subtraction angiography (DSA) provides reference data on the site, timing, and effectiveness of the flow stagnation as well as on the amount and direction of collateral circulation. This setting allows us to relate CW-NIRS findings to brain specific perfusion changes. We focused our analysis on the transition from normal perfusion to vessel occlusion, i.e., before hypoxia becomes clinically apparent. The localization of the maximal response correlated either with the core (occlusion of the middle cerebral artery) or with the watershed areas (occlusion of the internal carotid artery) of the respective vascular territories. In one patient with clinically and angiographically confirmed insufficient collateral flow during carotid artery occlusion, the total hemoglobin concentration became significantly asymmetric, with decreased values in the ipsilateral watershed area and contralaterally increased values. Multichannel CW-NIRS monitoring might serve as an objective and early predictive marker of critical perfusion changes during interventions—to prevent hypoxic damage of the brain. It also might provide valuable human reference data on oxygenation changes as they typically occur during acute stroke. 相似文献
102.
103.
Monique Zangarini Ezia Bello Luca Porcu Carlos M. Galmarini Luis F. García‐Fernández Carmen Cuevas Paola Allavena Eugenio Erba Maurizio D'Incalci 《International journal of cancer. Journal international du cancer》2013,133(9):2024-2033
This study: (i) investigated the in vitro cytotoxicity and mode of action of lurbinectedin (PM01183) and Zalypsis® (PM00104) compared with trabectedin in cell lines deficient in specific mechanisms of repair, (ii) evaluated their in vivo antitumor activity against a series of murine tumors and human xenografts. The antiproliferative activity, the DNA damage and the cell cycle perturbations induced by the three compounds on tumor lines were very similar. Nucleotide Excision Repair (NER) deficient cells were approximately fourfold more resistant to trabectedin, lurbinectedin and Zalypsis®. Cells deficient in non‐homologous end joining (NHEJ), MRN complex and translesion synthesis (TLS) were slightly more sensitive to the three compounds (approximately fivefold) while cells deficient in homologous recombination (HR) were markedly more sensitive (150–200‐fold). All three compounds showed a good antitumor activity in several in vivo models. Lurbinectedin and trabectedin had a similar pattern of antitumor activity in murine tumors and in xenografts, whereas Zalypsis® appeared to have a distinct spectrum of activity. The fact that no relationship whatsoever was found between the in vitro cytotoxic potency and the in vivo antitumor activity, suggests that in addition to direct cytotoxic mechanisms other host‐mediated effects are involved in the in vivo pharmacological effects. 相似文献
104.
Current perspectives in therapeutic myocardial angiogenesis 总被引:2,自引:0,他引:2
The complex mechanisms mediating the development of new blood vessels are now beginning to be unraveled. In conjunction with major biotechnology advances, this has facilitated the initiation of translational research related to a novel treatment strategy for patients with myocardial or leg ischemia due to obstructive arterial disease--therapeutic angiogenesis. At present, at least 17 clinical trials of myocardial angiogenesis have been presented involving over 900 patients. Uncertainty exists as to the optimal delivery route and angiogenic agent, and this uncertainty is reflected in the diverse methodology of the trials published thus far. The majority of patients received an angiogenic protein via the intracoronary route. Other delivery techniques--such as direct intramyocardial injection via transepicardial or transendocardial routes--and other angiogenic agents, including master genes, have also been studied. Most recently, interest has grown in the potential angiogenesis effects of cell therapy--such as autologous bone marrow cells or cultured stem cells--and there are now several groups initiating Phase I/II trials in this area. This review summarizes the current evidence pertaining to the safety, feasibility, and efficacy of various angiogenic techniques aimed at enhancing myocardial blood flow and alleviating angina. 相似文献
105.
106.
107.
Sergio Leonardi Felice Gragnano Greta Carrara Giuseppe Gargiulo Enrico Frigoli Pascal Vranckx Dario Di Maio Vanessa Spedicato Emanuele Monda Luigi Fimiani Vincenzo Fioretti Fabrizio Esposito Marisa Avvedimento Fabio Magliulo Attilio Leone Salvatore Chianese Michele Franzese Martina Scalise Marco Valgimigli 《Journal of the American College of Cardiology》2021,77(4):375-388
BackgroundContemporary definitions of bleeding endpoints are restricted mostly to clinically overt events. Whether hemoglobin drop per se, with or without overt bleeding, adversely affects the prognosis of patients with acute coronary syndrome (ACS) remains unclear.ObjectivesThe aim of this study was to examine in the MATRIX (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox) trial the incidence, predictors, and prognostic implications of in-hospital hemoglobin drop in patients with ACS managed invasively stratified by the presence of in-hospital bleeding.MethodsPatients were categorized by the presence and amount of in-hospital hemoglobin drop on the basis of baseline and nadir hemoglobin values and further stratified by the occurrence of adjudicated in-hospital bleeding. Hemoglobin drop was defined as minimal (<3 g/dl), minor (≥3 and <5 g/dl), or major (≥5 g/dl). Using multivariate Cox regression, we modeled the association between hemoglobin drop and mortality in patients with and without overt bleeding.ResultsAmong 7,781 patients alive 24 h after randomization with available hemoglobin data, 6,504 patients (83.6%) had hemoglobin drop, of whom 5,756 (88.5%) did not have overt bleeding and 748 (11.5%) had overt bleeding. Among patients without overt bleeding, minor (hazard ratio [HR]: 2.37; 95% confidence interval [CI]: 1.32 to 4.24; p = 0.004) and major (HR: 2.58; 95% CI: 0.98 to 6.78; p = 0.054) hemoglobin drop were independently associated with higher 1-year mortality. Among patients with overt bleeding, the association of minor and major hemoglobin drop with 1-year mortality was directionally similar but had wider CIs (minor: HR: 3.53 [95% CI: 1.06 to 11.79]; major: HR: 13.32 [95% CI: 3.01 to 58.98]).ConclusionsAmong patients with ACS managed invasively, in-hospital hemoglobin drop ≥3 g/dl, even in the absence of overt bleeding, is common and is independently associated with increased risk for 1-year mortality. (Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox; NCT01433627) 相似文献
108.
109.
ras and c-myc protein expression in colorectal carcinoma 总被引:6,自引:0,他引:6
Felice Miller M.D. Tomas M. Heimann M.D. Astrid Quish M.D. Daniel J. Pyo M.D. Arnold Szporn M.D. Giorgio Martinelli Ph.D. Thomas M. Fasy M.D. Ph.D. 《Diseases of the colon and rectum》1992,35(5):430-435
This study was performed to determine the correlation of tumor ras and c-myc oncogene expression with clinical and prognostic variables in patients prone to develop colorectal cancer. One hundred eighteen patients with colorectal cancer were studied; mean age was 40 years. Fifty-three were young patients (age 40 or less), 49 had ulcerative colitis, and 16 had multiple polyposis coli. Immunoperoxidase stains of paraffin-embedded cancer sections were performed for the c-myc and ras proteins. ras staining was found to correlate with Dukes stage and prognosis. Patients with tumors negative for ras protein stain had an actuarial five-year survival of 61 percent versus 44 percent for those tumors with a positive stain (P less than 0.05). This correlation was not seen with the c-myc stain. Positive ras oncogene stain appears to be a useful indicator of advanced stage and poor prognosis in colorectal cancer occurring in cancer-prone patients. 相似文献
110.
C. Dionisi-Vici L. De Felice M. El Hachem S. Bottero C. Rizzo A. Paoloni B. Goffredo G. Sabetta M. Caniglia 《Journal of inherited metabolic disease》1998,21(2):95-102
In addition to systemic manifestations with skeletal, pulmonary, renal, and haematological signs, lysinuric protein intolerance (LPI), a membrane transport defect of cationic amino acids, is often complicated by severe life-threatening immunological manifestations. A 10-year-old boy with LPI who exhibited a severe systemic immunohaematological disease is described here. This patient showed cutaneous lesions similar to the subacute form of systemic lupus erythematosus, severe anaemia and dysproteinaemia, and a marked reduction of circulating T lymphocytes, mainly the CD4+ cells. In vitro bone marrow cell culture studies showed that addition of patient's serum induced macrophage proliferation and inhibited erythroid progenitor cell growth. Treatment with high-dose intravenous immune globulin resolved most of the clinical and laboratory abnormalities. 相似文献